微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -3.33% | -195.97% | 24.83% | 43/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -4.43% | 96.21% | -310.19% | 48/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -1.08% | 93.01% | -131.12% | 41/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-09-30 | 3.47% | 8.44% | 102.97% | 32/51 | 6.82% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-06-30 | -116.83% | -398% | -655.69% | 49/51 | 1.93% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-03-31 | -15.46% | -1710.42% | 93.1% | 48/51 | 2.58% | 澳洋健康 | 48.34% | 行业排名> |
| 2022-12-31 | -223.94% | -29.65% | -7098.13% | 50/51 | -0.62% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-09-30 | 3.2% | 108.52% | 113.64% | 33/51 | 11.4% | *ST宜康 | 75.53% | 行业排名> |
| 2022-06-30 | -23.46% | 15.15% | -2543.75% | 49/51 | 5.56% | 博腾股份 | 39.77% | 行业排名> |
| 2022-03-31 | 0.96% | -72.88% | 100.56% | 29/51 | 3.14% | 睿智医药 | 41.16% | 行业排名> |
| 2021-12-31 | -172.73% | -787.07% | -359.88% | 48/51 | -6.68% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-09-30 | -37.56% | -79.03% | -35.84% | 37/51 | 2.3% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-06-30 | -27.65% | -16.03% | -881.07% | 47/51 | 2.28% | 金域医学 | 43.58% | 行业排名> |
| 2021-03-31 | 3.54% | 138.56% | -85.92% | 13/51 | 1.79% | 金域医学 | 35.41% | 行业排名> |
| 2020-12-31 | 25.14% | -99.12% | 219.83% | 10/51 | 10.95% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-09-30 | -20.98% | -121.2% | 11.96% | 33/51 | 7.83% | 金域医学 | 13.23% | 行业排名> |
| 2020-06-30 | -23.83% | -128.9% | -159.59% | 39/51 | 2.48% | 万邦医药 | 52.05% | 行业排名> |
| 2020-03-31 | -9.18% | -118.96% | -100.32% | 31/51 | -0.22% | 华大基因 | 48.52% | 行业排名> |
| 2019-12-31 | 2848.07% | 690.58% | 2777.42% | 1/51 | 65.31% | 华大基因 | 31.24% | 行业排名> |
| 2019-09-30 | 98.98% | 156.51% | 20.03% | 1/51 | 10.68% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-06-30 | 82.46% | 195.2% | 70.34% | 1/51 | 5.65% | 南华生物 | 2848.07% | 行业排名> |
| 2019-03-31 | 48.41% | 239.99% | 110.04% | 1/51 | 3.54% | 南华生物 | 98.98% | 行业排名> |
| 2018-12-31 | -482.25% | -69.89% | -175.34% | 47/51 | -0.6% | 南华生物 | 82.46% | 行业排名> |
| 2018-09-30 | -175.15% | 92.15% | -102.21% | 28/51 | 2.62% | 南华生物 | 48.41% | 行业排名> |
| 2018-06-30 | -86.62% | -105.2% | -150.49% | 33/51 | 1.51% | 万邦医药 | 106.72% | 行业排名> |
| 2018-03-31 | -34.58% | 80.06% | 87.82% | 27/51 | 0.52% | 国际医学 | 46.66% | 行业排名> |
| 2017-12-31 | -283.86% | -174.11% | -117.03% | 42/51 | 1.73% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-06-30 | 1666.98% | 2930.32% | 1061.24% | 1/51 | 60.47% | 通策医疗 | 6.02% | 行业排名> |
| 2017-03-31 | -173.42% | -801.25% | -145.28% | 23/51 | -5.59% | 普蕊斯 | 58.68% | 行业排名> |
| 2016-12-31 | 383.03% | -4.44% | 596.29% | 1/51 | 23.06% | 爱尔眼科 | 20.87% | 行业排名> |
| 2016-06-30 | 55.01% | 107.94% | 122.44% | 1/51 | 4.57% | 南华生物 | 1666.98% | 行业排名> |
| 2016-03-31 | 24.73% | 118.21% | -93.83% | 1/51 | 1.51% | 爱尔眼科 | 5.19% | 行业排名> |
| 2015-12-31 | 400.84% | 179.38% | 157.85% | 1/51 | 22.23% | 南华生物 | 383.03% | 行业排名> |
| 2015-06-30 | -692.85% | 60.77% | -410.16% | 21/51 | -30.81% | *ST宜康 | 36.84% | 行业排名> |
| 2015-03-31 | -135.81% | 23% | 73.11% | 20/51 | -5.77% | 药石科技 | 24.53% | 行业排名> |